Kenya is home to a budding pharma sector, but the country still faces access to medicine challenges. What are they, and how can pharma help?

Nurses are vital healthcare team members and are often underutilised in antimicrobial stewardship (AS) activities. Several nursing responsibilities, such as taking allergy history and obtaining cultures, already overlap with AS activities.

The scientific community has made great strides in responding to the huge public health problems of obesity and diabetes with the discovery of the incretin system and the development of glucagon-like peptide 1 analogues.

A first-in-class vaccine for respiratory syncytial virus has shown to be highly efficacious in a Phase III trial, GSK has announced.

Essential hypertension, a significant risk factor for cardiovascular diseases (CVD), kidney failure, and all-cause mortality, is largely reversible with lifestyle changes and highly efficacious medications. However, the prevalence of raised blood pressure (BP) is increasing globally. Considering its lack of symptoms, many people remain undiagnosed and unaware of the risks. In addition, a lack of perceived benefit makes adhering to pharmacological and non-pharmacological interventions challenging for patients.

Secondary hyperparathyroidism (SHPT) is a common and early complication of chronic kidney disease (CKD). Patients with uncontrolled SHPT have high parathyroid hormone (PTH) levels due to mineral metabolism disturbances of several biochemical parameters. These elevated PTH levels put patients at an increased risk of cardiovascular disease and bone fractures. This infographic explores the current treatments available to treat mineral bone disease in CKD (CKD-MBD) and their failure to achieve balance across key disease parameters.